Pharmaceutical-grade peptides. Compounded, batch-tested, dosed to your biomarkers.
Not gray-market. Not influencer guesswork. Clinician-built peptide stacks sourced from a licensed 503A compounding pharmacy, prescribed by a specialist who reads your labs every quarter — not your TikTok feed.
Biomarker Dashboard
Q2 PanelIllustrative composite. Individual results vary. RenewRx does not guarantee specific outcomes.
"The peptide you buy online is probably not the peptide on the label."
Gray-Market "Research" Vendor
Unknown molecule. Unknown purity. Unknown outcome.
- No clinician oversight — contact form only
- No batch testing or sterility verification
- "For research purposes only" — unenforceable
- No lab monitoring before or after
- Wildly inconsistent purity across lots
- Contamination risk on injectables
- No dose titration or protocol adjustment
RenewRx Protocol
Prescribed molecule. Verified purity. Measured outcome.
- Board-certified clinician builds your protocol
- 503A compounding pharmacy — state-licensed
- Every batch purity and sterility verified
- 50+ marker panel before, during, and after
- Individualized dosing based on your biomarkers
- Quarterly re-panels with protocol adjustment
- Transparent pricing, no gray-area risk
Clinician-built stacks for recovery, longevity, and performance
Your protocol is built from your goals, your labs, and your history — not a category page. These are representative stacks we use as starting points.
Tissue & Injury Stack
For athletes and high-training adults recovering from injury, surgery, or chronic overuse. Focus: accelerated soft-tissue healing, reduced inflammation, joint support.
- Gut & connective tissue repair
- Stimulate targeted angiogenesis
- Targeted anti-inflammatory support
- Recovery biomarker monitoring
Growth Hormone Axis Stack
For adults 35+ with declining IGF-1 and growth hormone markers. Focus: lean mass, sleep quality, deep recovery, skin and tissue integrity.
- Naturally stimulate Growth Hormone
- Improve vitality, energy, and recovery
- Modulate and improve sleep quality
- Contraindication screening first
NAD+ & Mitochondrial Stack
For cognitive sharpness, energy, and mitochondrial health. Focus: NAD+ restoration, oxidative stress reduction, metabolic flexibility.
- NAD+ injection or IV
- Optional peptide adjuncts
- NAD+ & hs-CRP tracking
- Metabolic panel every 90 days
Stacks shown are representative starting points. Every RenewRx protocol is individualized to the patient's labs, goals, and screening results. Peptide therapy is a regulated medical intervention and requires a clinical evaluation.
We measure. We consult with you. We optimize accordingly.
Most peptide providers tell you how you'll feel. We show you the biomarker that moved. Quarterly panels, transparent trending, protocol adjustment based on the data — not the vibe.
Illustrative Biomarker Deltas — 90 Days
What we track — because this is a medical intervention, not a supplement
Every RenewRx patient gets a full-panel draw at baseline, 90 days, and every 90 days thereafter. These panels target the system your protocol is actually optimizing.
If a marker doesn't move, we change the protocol. If a marker moves in the wrong direction, we change the protocol. That's the loop — and it's what separates real optimization from $300 worth of peptide LARPing.
Honest note: peptide research is evolving. RCT evidence is strongest for some molecules (e.g., NAD+, Sermorelin, Ipamorelin axis) and weaker for others. We screen for contraindications, we review and explain what's known and unknown, and we do NOT make magical claims. When we treat for "restoring & optimizing" — we mean it.
Test. Prescribe. Re-test. Optimize.
The same clinical rigor we apply to TRT and BHRT — applied to peptides and longevity protocols.
90-Second Quiz
Tell us your goals, training context, and current stack. We route you to the right clinical track.
Full Biomarker Panel
50+ markers covering the GH axis, inflammation, metabolic health, lipids, and performance indicators.
1:1 Clinician Consult
A specialist reviews your panel, screens contraindications, and builds your individualized protocol.
Quarterly Re-Panel
Biomarker delta review every 90 days. Dose, molecule, and timing adjusted against actual data.
The clinician who will oversee & run your protocol
Peptide therapy is regulated, nuanced, and evolving. You want someone who screens contraindications, watches for red flags, and adjusts based on data — not someone copy-pasting a forum post.
Tyler Coe, NP
- Board-Certified Nurse Practitioner
- A4M / Fellowship-trained
- Peptide therapy certified
- Functional medicine training
- Quarterly biomarker-driven protocols
- BHRT & peptide therapy certified
What biohackers say after 90 days
De-identified patient quotes. Outcomes vary; RenewRx does not guarantee specific results.
"I need pharma-purity, batch-tested peptides — not gray-market guesses. RenewRx was the first place that took my biomarker stack seriously and tied the protocol directly to it. IGF-1 up, hs-CRP down, HRV meaningfully better."
"My recovery time dropped roughly in half once the BPC-157 + GH-axis stack was dialed. Training volume is where it was in my early 30s. The difference is that every dose is tied to a lab value, not a guess."
"Show me the data, not the testimonial. That's what I said to the consult. They showed me the baseline, the 90-day delta, and what they planned to change. That's the only peptide provider I've worked with that operated like actual medicine."
Questions biohackers ask before starting
Yes, we've read the studies too.
What's the RCT evidence for peptides like BPC-157 and CJC/Ipamorelin?
It's mixed, and we won't pretend otherwise. The GH-secretagogue class (Sermorelin, Ipamorelin, CJC-1295) has stronger human data than BPC-157, which is mostly preclinical. We prescribe based on the peptide's FDA availability, weight of evidence, clinical experience, and — critically — biomarker response. If your 90-day IGF-1, inflammatory markers, or recovery metrics don't move, we change the protocol. We don't sell faith.
Is there a cancer risk with GH-axis peptides?
The theoretical concern is that elevating IGF-1 could accelerate pre-existing malignancies. There is no strong RCT evidence that GH secretagogues at therapeutic doses increase cancer risk in screened patients, but we take this seriously. We screen for history and red flags, we monitor IGF-1 to stay inside the physiologic range (not stack it to the ceiling), and we do not prescribe to patients with certain contraindications. If you have a concern, we'll talk through it directly.
What if the FDA restricts 503A compounding?
FDA posture on 503A-compounded peptides has shifted several times. We monitor this continuously and will adjust our formulary if the regulatory picture changes. Our 503A partner pharmacy is state-licensed and inspected, which is the most robust version of compounded sourcing currently available.
Can I bring my own biomarker panel (e.g., Function Health, Quest)?
Usually yes. If you already have recent panels, share them — we may only need to order a smaller supplemental draw to fill gaps. We don't do lab-work-for-lab-work's-sake; we target the markers that matter for your specific protocol.
How does peptide therapy interact with TRT or BHRT?
Often synergistically, but the order matters. For most patients we recommend getting hormonal status dialed in first (TRT/BHRT), then layering peptides. Running GH-axis peptides on top of poorly-managed testosterone or thyroid is a common way to waste money. We sequence properly.
What does it cost?
Depends on the protocol — a single-peptide recovery stack is dramatically less than a full multi-peptide longevity stack with quarterly panels. The quiz returns a transparent cost range for your specific goals before you ever speak with a clinician. We don't do bait-and-switch pricing.
Stop guessing. Start measuring.
Take the 90-second eligibility quiz. If you're a fit, we'll book your consult, run your baseline biomarker panel, and build your protocol against the data.
Call Us Now